Zimmer Biomet Holdings (ZBH) Reports In-Line Q4 EPS; Guides Q1 Modestly Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Zimmer Biomet Holdings (ZBH) Reports In-Line Q4 EPS; Guides Q1 Modestly Below the Street
January 31, 2018 8:18 AM EST
Baird raised its price target on Zimmer Biomet (NYSE: ZBH) to $138.00 (from $130.00) while maintaining a Outperform rating, following the company's fourth quarter earnings report.
Analyst Jeff Johnson notes a positive outlook on the shares, as ZBH reported fourth revenues above consensus... More
January 31, 2018 7:50 AM EST
Leerink Partners raised its price target on Zimmer Biomet (NYSE: ZBH) to $146.00 (from $142.00) while maintaining a Outperform rating.
Analyst Richard Newitter commented, "Our OP rating is predicated on the view that for longer-term oriented investors we believe ZBH is a turnaround... More
January 30, 2018 1:11 PM EST
Needham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $155.00 (from $144.00) while maintaining a Strong Buy rating following in-line Q4 results.
Analyst Mike Matson commented, "ZBH's 4Q17 revenue beat and EPS met consensus and 1Q18 guidance was below consensus. Margins... More
